Clinical Trial

High Neutrophil-to-Lymphocyte Ratio and Patients With Hemodialysis

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 17, 2025 (before its estimated February 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
To explore the role of neutrophil-to-lymphocyte ratio ( NLR ) and platelet-to-lymphocyte ratio ( PLR ) in predicting mortality in hemodialysis (HD) patients.
Trial Details
NCT Number NCT07070557
Lead Sponsor Sohag University
Conditions Hemodialysis Patient
Enrollment 100 participants
Start Date 2025-07-15
Primary Completion 2026-02-15 (estimated)
Study Completion 2026-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-17